CD8A and COVID-19: In the acute COVID-19 phase, we observed differences between severe and mild cases, including significantly lower absolute counts of CD3+ T lymphocytes, CD4+ helper T cells, CD8+ cytotoxic T cells, and NK cells in the severe subgroup.